chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hip pain; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program. A female patient of an unspecified age received first dose of BNT162B2 (COMIRNATY, Solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration on 02Feb2021 at afternoon as 1ST DOSE, SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date after vaccination, the patient experienced hip pain. Outcome of the event was unknown.  Information about lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.
Normally gets migraine; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Normally gets migraine) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 002B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Normally gets migraine). The patient was treated with PARACETAMOL (TYLENOL) for Migraine, at a dose of 1 dosage form; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date for Migraine, at a dose of 1 dosage form and IBUPROFEN (MOTRIN [IBUPROFEN]) for Migraine, at a dose of 1 UNK. At the time of the report, MIGRAINE (Normally gets migraine) outcome was unknown. Not Provided          No concomitant medication were reported The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 05-APR-2016 the patient was vaccinated with an improperly stored dose of (Wistar ra 27-3) M-M-R II 0.5 ml (lot #L003856, expiration date 02-FEB-2017, therapy type recombinant human albumin (rHA), dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time 48 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine were refrigerator (R)/ freezer (F). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Patient tested positive for COVID on 2.4.21.  "Negative COVID test on 1/20/21;  Reason for testing on 2/4/21 - Contact with and (suspected) exposure to other viral communicable disease".  Symptoms reported on COVID-19 scheduling questions: Nasal congestion, sore throat and fatigue with date of symptom onset 2/4/21.
Donor returned to center on 9/17/19 stating that he started feeling sick to his stomach, weak, nausea, belching, leg spasms, tired and exhausted, and lightheadedness on 9/14/19 around 12:00 pm after receiving the vaccine at 9:29 am on 9/14/19.  Donor stated that this feeling lasted until 9/16/19 around 12:00 pm and that he felt like a million dollars on 9/17/19.
What is being described as Covid arm. Red itchy rash at site of injection as well as swelling and bruising. Rash and swelling began around 5 days after injection. No treatment has been needed.
I developed shingles on 4/2/21 after receiving my first vaccine on 2/2/21 and my second vaccine on 2/23/21.  I reported to the  department of health and they asked me to fill this form out.  My daughter also received 1st vaccine on 4/21/2021 and when I saw her on 5/4/2021 she had developed shingles as well.  She refused the second vaccine against my advice.  I have an autoimmune disease of Diabetes and I have arthritis.  She does not except she has asthma.  I just felt like someone needed to be aware in case you did follow ups on this type of complication.
Three to five days post second Hepatitis B vax, pt developed local papular, pustular rash around injection site.
pt recvd vax 1PM about 5PM began crying, t101 ax, cried & screamed until 10PM; fever broke; took formula & did sleep;
Numbness/tingling to left arm extending to fingers. Recurrent twitching to left arm and lateral portion of hand lasting from 3-5 mins.
24 hours after injection large area of errythema surrounding the injection site, hot and painful to the touch.  Also c/o fever and chills. T=100.5
Syncope (fainting) occurred 2 to 3 minutes after administering the vaccine. Patient started  reaction by saying he is not feeling well , then immediately appeared to be loosing consciousness. pharmacist assisted patient immediately to lie down flat on the floor to prevent falls and injuries. Paramedic were notified. Patient then started saying they feel a bit better and mentioned he had history of fainting after seeing needles and usually get very anxious in similar vaccine situations. Around 15 minutes after incident patient was completely recovered , he refused to be transported to hospital when checked by paramedics and left facility with no injuries and felling  well.
Gave the last 2 doses after the 6hs punctured vial lifespan; A spontaneous report was received from a consumer concerning a patient of unknown age and gender who received Moderna's COVID-19 vaccine who received (mRNA-1273) and the person that was administering the doses gave the last two doses after the six hour of vaccine viability time (expired product administered).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unspecified date, the patient received a dose of mRNA-1273 (lot number not provided) for prophylaxis of COVID-19 infection.  It was reported that the person that was administering the doses gave the last two doses after the six hour of vaccine viability time.    No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The event gave the last two doses after the six hour of vaccine viability time was considered resolved.; Reporter's Comments: This case concerns a patient of unknown age and gender who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Expired product administered without any associated adverse events.
Same day- PNEUMOVAX 23 after administered left arm was hot and heavy. Severe arm pain /heaviness, headache, decreased appetite, fatigue, palpitations. Stays in bed for 3 days due to severe exhaustion.
Residents was previously positive for Covid-19 on 6/17/20.  She received both doses of the Pfizer vaccine.  She tested positive again for Covid-19 on 2/10/21.
pt recv vax 4JAN95 & w/in 24 hr of vax pt devel rash on rt arm that was red, swollen almost to the elbow, was very hot to touch & painful throughout entire arm which lasted for over a week;pt recovered;
Pt recv vax in 12/95; post vax pt exp fussy, refusal to nurse, high-pitched cry
I vomited 4 times which was all mostly stomach acid. I had nausea for the next 3 days. I was feeling fatigued and had muscle pain in my legs and back. I was feeling feverish and had chills. It took me about four days to feel better again. I have PCOS and noticed more ovarian pain and symptoms relating to it during those 4 days of recovery.
Pt developed swelling in right leg beginning 1 day post vax. It was red, hard, and hot to touch. Parent took to ER on 3rd day post vax.
Public Health Nurse gave patient full dose .5mg MODERNA vaccine as the Janssen booster instead of the half dose .25 mg. On day two, patient reported a severely sore site of administration (patient applied ice pack) as well as uncomfortable gastrointestinal issues. PHN encouraged patient to take their familiar comfort meds for relief. Patient did not report fever. By day four, patient reported that it was a little better.
pain; rash was painful for 3 days; a shingle like burning, itching, at the lower abdominal area; shingle like burning; mild discomfort; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (a shingle like burning, itching, at the lower abdominal area), BURNING SENSATION (shingle like burning), DISCOMFORT (mild discomfort), PAIN (pain) and RASH (rash was painful for 3 days) in a 70-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     Patient had no COID-19 diagnosis.  The patient's past medical history included Central serous chorioretinopathy (Central series retinopathy, diagnosed before any of the COVID-19 vaccine.), Arrhythmia (diagnosed before any of the COVID-19 vaccine.) and Retinal ischaemia (Retinal transient ischaemic attack.  diagnosed after March 2022). Previously administered products included for Product used for unknown indication: Flu shot (a week prior the Spikevax shot and patient had the flu shot.). Past adverse reactions to the above products included No adverse event with Flu shot. Concurrent medical conditions included Cystitis interstitial (diagnosed before any of the COVID-19 vaccine.) and Irritable bowel (diagnosed before any of the COVID-19 vaccine.).    On 24-Sep-2023, the patient received sixth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 25-Sep-2023, the patient experienced PRURITUS (a shingle like burning, itching, at the lower abdominal area), BURNING SENSATION (shingle like burning) and DISCOMFORT (mild discomfort). On an unknown date, the patient experienced PAIN (pain) and RASH (rash was painful for 3 days). At the time of the report, PRURITUS (a shingle like burning, itching, at the lower abdominal area) and BURNING SENSATION (shingle like burning) outcome was unknown, DISCOMFORT (mild discomfort) and PAIN (pain) had resolved and RASH (rash was painful for 3 days) was resolving.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Patient received 6th dose a week ago on Sunday. Post vaccination morning patient developed a rash, a shingle like burning, itching, at the lower abdominal area, there were found 3 spots. Patient visited a dermatologist and dermatologist thought it might be related to the vaccine and maybe a mild case of Shingles. Dermatologist prescribed antiviral treatment medication, but patient chose not to take it. It has been reported that rash was painful for 3 days. Patient took treatment medication steroid ointment as per prescription strength, but it did not help much to patient.  Patient did not have information on previous doses, but all were Moderna vaccines. And patient mentioned that on 26-Apr-2023, received Moderna Bivalent dose.   This case was linked to US-MODERNATX, INC.-MOD-2023-743144 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-743144:2nd dose (MODERNA COVID-19 VACCINE)
temperature 99-101, very sore arm, body aches, headaches for 2 days
injection site warm; area of injection had large spot; injection site itchness; injection site red; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (injection site warm), VACCINATION SITE SCAR (area of injection had large spot), VACCINATION SITE PRURITUS (injection site itchness) and VACCINATION SITE ERYTHEMA (injection site red) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included TAMSULOSIN, TRIAMCINOLONE ACETONIDE (NASACORT) and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced VACCINATION SITE WARMTH (injection site warm), VACCINATION SITE SCAR (area of injection had large spot), VACCINATION SITE PRURITUS (injection site itchness) and VACCINATION SITE ERYTHEMA (injection site red). The patient was treated with CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (injection site warm), VACCINATION SITE SCAR (area of injection had large spot), VACCINATION SITE PRURITUS (injection site itchness) and VACCINATION SITE ERYTHEMA (injection site red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Got very sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Got very sick) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Got very sick). At the time of the report, ILLNESS (Got very sick) outcome was unknown.            No concomitant medication reported . No treatment medication reported .   This case was linked to MOD-2021-281964 (Patient Link).
Employee presented to employee health department after receiving the hep b immunization 2 1/2 hours prior complaining of dizziness/ lightheadeness. Sweaty and breathing faster after watching her in our off for about an hour symptoms resolved and there were no other problems or symptoms since,
Patient received Pfizer COVID-19 vaccine stored in regular freezer for longer than 2 weeks.
got the flu; Initial information was received on 05-Jan-2021 regarding an unsolicited valid non-serious social media case from a consumer.  This case is linked to case 2021SA003714 (same reporter).  This case involves male patient (unknown age) who got the flu (influenza), while he received INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious had the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
This spontaneous report as received from a Certified Medical Assistant (CMA) (also reported as healthcare professional) refers to unspecified patients of unknown age. The healthcare reported that improperly stored RECOMBIVAX HB were administered to an unspecified number of patients, demographics unspecified. No adverse effects were reported. It was unspecified if patients sought medical attention. This is one of several reports from the same reporter. Additional information is not expected.
fluid came out of injection site; A spontaneous report was received from a consumer concerning a male patient who received Modern's COVID-19 vaccine (mRNA-1273) and as soon the needle was removed from the injection site, fluid came out, not blood, pink fluid.  The patient's medical history was reported as cancer for 18years. Relevant concomitant medications reported were Finasteride 5 mcg and Tamsulosin 0.4mcg.    26-jan-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 012M20A) for prophylaxis of COVID-19 infection, as soon the needle was removed from the injection site, fluid came out, not blood, pink fluid, so the provider cleaned that and after the fluid continues going out and provider cleaned again.  No Laboratory details provided.  No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported.   At the time of this report, the outcome of the event injection site extravasation is Unknown.
severe pruritis; rashes; , terrible, severe she would stand in the corner scratching her head and crying so bad.  It started at her head then escalated to her entire body- back, neck, stomach; Five months later she developed hive, terrible, severe, It started at her head then escalated to her entire body- back, neck, stomach,; UTI infections; Crying so bad; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received bnt162b2 (COVID 19 VACCINE, mRNA, solution for injection, Lot Number: EN6201, Expiry Date: Unknown, NDC Number: Unknown), dose 2 via an unspecified route of administration on 16Feb2021 (at the age of 74 years old) as dose 2, single for COVID-19 immunisation. No PQC was present. Investigation assessment was done. Medical history included ongoing osteopetrosis, Lymph node. The patient previously took bnt162b2 (COVID 19 VACCINE, mRNA, solution for injection, Lot Number: EL9261), dose 1 via an unspecified route of administration on 26Jan2021 (at the age of 74 years old) as dose 1, single for COVID-19 immunisation. Concomitant medication(s) included Prolia taken for osteopetrosis. On Jul2021, the patient experienced five months later she developed hive, terrible, severe she would stand in the corner scratching her head and crying so bad, it started at her head then escalated to her entire body- back, neck, stomach, severe pruritis, rashes. On an unspecified date of 2021, the patient experienced UTI infections, crying so bad. The patient underwent lab tests and procedures which included biopsy resulted unknown on an unspecified date of 2021, blood test resulted unknown on an unspecified date 2021 blood was affected again (further not clarified), ultrasound scan resulted unknown on an unspecified date 2021. Therapeutic measures were taken as a result of five months later she developed hive, terrible, severe she would stand in the corner scratching her head and crying so bad, it started at her head then escalated to her entire body- back, neck, stomach, severe pruritis, rashes, UTI infections, crying so bad. Reporter stated that she was afraid to get the booster, but she was also afraid of not getting the booster and not having full coverage from Covid. She has seen every doctor and allergist about this. Reporter stated I am still going to doctor. Now I got to go to haematologist, and I am trying to figure it out why it just happened to me so I went out on the website so there was couple of cases reported of chronic idiopathic hive, so I want to make sure before I have the booster if it was safe for me to go for this booster. All those things I am not allergic (not clarified), I have never had a problem with my dentist, my endocrinologist, dermatologist radiologist everybody, neurologist to everybody. The clinical outcome of the events was reported as unknown.  Further information needed. Further information is expected.  Follow-up attempts are completed. No further information is expected.
Flu; being sick; Initial information received on 05-Feb-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves Adult and unknown gender patient who had flu while receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine for immunization produced by unknown manufacturer via unknown route and administration site and lot number was not reported .  On an unknown date the patient developed a non-serious events are "flu (influenza) (unknown latency) and being sick (illness) (unknown latency)" following the administration of influenza vaccine. It was reported that the patient take the flu shot every year, this year the patient took this shot in October, sick that night, next day Patient was fine and again got sick about two weeks ago and patient was tested twice for covid and both times it came back Negative for corvid but tested pos. For the flu, just got over being sick for two weeks with the flu.  Action taken with Influenza vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the events (being sick, Flu).  At time of reporting, the outcome was Unknown for the event flu.
she come across with term called "COVID ARM". She read about it. She seems like that is what she had; it was very itchy; bright red patch in injection site, 8 inches long 4 inches wide; it was warmer than rest of my skin; same day achy arm lasted for day; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (same day achy arm lasted for day), INJECTION SITE WARMTH (it was warmer than rest of my skin), VACCINATION SITE PHOTOSENSITIVITY REACTION (she come across with term called "COVID ARM". She read about it. She seems like that is what she had), VACCINATION SITE PRURITUS (it was very itchy) and VACCINATION SITE ERYTHEMA (bright red patch in injection site, 8 inches long 4 inches wide) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for an unknown indication.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (same day achy arm lasted for day). On 18-Feb-2021, the patient experienced INJECTION SITE WARMTH (it was warmer than rest of my skin), VACCINATION SITE PRURITUS (it was very itchy) and VACCINATION SITE ERYTHEMA (bright red patch in injection site, 8 inches long 4 inches wide). On an unknown date, the patient experienced VACCINATION SITE PHOTOSENSITIVITY REACTION (she come across with term called "COVID ARM". She read about it. She seems like that is what she had). On 16-Feb-2021, PAIN IN EXTREMITY (same day achy arm lasted for day) had resolved. On 01-Mar-2021, INJECTION SITE WARMTH (it was warmer than rest of my skin), VACCINATION SITE PRURITUS (it was very itchy) and VACCINATION SITE ERYTHEMA (bright red patch in injection site, 8 inches long 4 inches wide) had resolved. At the time of the report, VACCINATION SITE PHOTOSENSITIVITY REACTION (she come across with term called "COVID ARM". She read about it. She seems like that is what she had) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were given. Treatment information include benadryl liquid and anti itch cream.   This case was linked to US-MODERNATX, INC.-MOD-2021-041286 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-041286:Dose 2 case